Lamar Odom doubled down on his previous claims that he did not do drugs the night of his near-fatal overdose in 2015, saying that he believes drugs were “slipped into” his drink at the Nevada ...

Pharmacy Benefit Managers are third-party companies connected to pharmacies that are intermediaries between insurance providers and pharmaceutical manufacturers and claim ... form of the leukemia ...

A LAUGHING drug dealer who filmed himself with wads of ... The dealer laughed as he told the call operator: "Obviously I haven't had my payment and I'm obviously skint." Raven then picks up ...

Mylan is now part of Viatris. Mylan did not admit to any wrongdoing, and neither did Pfizer, which settled related claims from the drug wholesalers for $50 million in 2023. A representative for ...

KOTA KINABALU: An assistant chief director and an assistant officer of the National Anti-Drug Agency (AADK) here were charged for making false claims amounting RM138,570 between 2018 and 2019.

Okubo, chief of the directorial staff, has been instructed to form a dedicated ... alleged cover-up of the 2022 drug case in a Palace briefing. The PNP denied the claim, saying that if there ...

President Joe Biden just announced that victims of the devastating California wildfire are eligible to receive a one-time payment of $770 ... and even prescription drugs. In a White House press ...

President Joe Biden said victims of the California fires are eligible for a $770 payment ... only one form of assistance to disaster victims. We wrote about similar claims that circulated in ...

California wildfire victims are eligible for a one-time $770 payment so they can "quickly ... gasoline and prescription drugs. The Serious Needs Assistance Program is one of a number of FEMA ...

President Joe Biden announced that victims of the California wildfires will be eligible for a $770 one-time payment meant to be used on essential items like water, prescriptions and paying for ...

Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, potentially outperforming current treatments. Listen to Story Experimental drug ...